Scleroderma: A Review of Vascular Features

Campbell PM LeRoy EC . Pathogenesis of systemic sclerosis: A vascular hypothesis. Semin Arthritis Rheum 1975; 4: 351–68.

Kahaleh MB . The role of vascular endothelium in the pathogenesis of connective tissue disease: Endothelial injury, activation, participation and response. Clin Exp Rheumatol 1990; 8: 595–601.

Maricq HR Harper FE Khan MM Tan EC LeRoy EC . Microvascular abnormalities as possible predictors of disease subsets in Raynaud's phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1: 195–205.

Smith EA LeRoy EC . Systemic sclerosis. Etiology and pathogenesis. In: Klippel JH Dieppe PA eds. Rheumatology, Volume vmr-6. St. Louis: Mosby, 1994: 9.1–9.10.

Lippton HL Hauth TA Summer WR Hyman AL . Endothelin produces pulmonary vasoconstriction and systemic vasodilatation. J Appl Physiol 1989; 66: 1008–12.

Brain SD Tippins JR Williams TJ . Endothelin induces potent microvascular constriction. Br J Pharmacol 1988; 95: 1005–1007.

Hirata Y Yoshimi H Takata S Cellular mechanism of action by a novel vasconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 1988; 154: 868–75.

Kurihara H Yoshizumi M Sugiyama T Transforming growth factor β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Comm 1989; 159: 1435–40.

Meidell RS , Southwestern Internal Medicine Conference. Endothelial dysfunction and vascular disease. Am J Med Sci 1994; 307: 378–89.

Smith EA . Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 1992; 4: 869–77.

Yamakage A Kikuchi K Smith EA LeRoy EC Trojanowska M. Selective upregulation of platelet-derived growth factor α receptors by transforming growth factor β in scleroderma fibroblasts. J Exp Med 1992; 175: 1227–34.

Kahaleh MB . Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum 1991; 34: 978–83.

Lüscher TF . Endothelin, endothelin receptors, and endothelin antagonists. Curr Opin Nephrol Hypertens 1994; 3: 92–98.

Wagner OF Christ G Wojta J Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992; 267: 16066–68.

Palmer RMJ Ashton DS Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–66.

Moncerda S Higgs A. The L-arginine–nitric oxide pathway. N Engl J Med 1993; 329: 2002–12.

Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: Appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 1991; 17 (suppl 3): S25–S33.

Cachofeiro V Sakakibara T Nasjletti A. Kinins, nitric oxide and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension 1992; 19: 138–45.

Pepke-Zaba J Higenbottam TW Dinh-Xuan AT Stone D Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173–74.

Kahaleh MB Fan PS Matucci-Cerinic M Stefanovic-Racic M Ignarro L. Study of endothelial dependent relaxation in scleroderma [Abstract]. Arthritis Rheum 1993; B233: S180.

Christman BW McPherson CD Newman JH An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70–75.

Bevilacqua MP Nelson RM . Selectins. J Clin Invest 1993; 91: 379–87.

Cronstein BN Weissmann G. The adhesion molecules of inflammation. Arthritis Rheum 1993; 36: 147–57.

Carson CW Beall CL Hunder GG Johnson CM Newman W. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheumatol 1993; 20: 809–14.

Claman AN Giorno RC Seibold JR . Endothelial and fibroblastic activation in scleroderma. The myth of the ‘uninvolved skin’. Arthritis Rheum 1991; 34: 1495–501.

Kahaleh MB Osborn I LeRoy EC . Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma. Ann Intern Med 1982; 96: 610–13.

Ware JA Heistad DD . Platelet–endothelium interactions. N Engl J Med 1993; 328: 628–35.

Kahaleh MB Osborn I LeRoy EC . Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med 1981; 94: 482–84.

Kahaleh MB Scharstein KK LeRoy EC . Enhanced platelet adhesion to collagen in schleroderma. Effect of scleroderma plasma and scleroderma platelets. J Rheumatol 1985; 12: 468–71.